Work

Hierarchical endpoints analyzed using the win‐ratio method as a practical innovation for deprescribing trials

Year: 2024

Type: article

Abstract: Dr. Goyal has received consulting fees from Agepha Pharma, Akros Pharma, Axon therapies, Bayer HealthCare Pharmaceuticals, and Sensorum Health; and has received personal fees for medicolegal consulting and expert testimony related to heart failure. Dr. Ambrosy has also received relevant research support through grants to his institution from The Permanente Medical Group, Northern California Community Benefits Programs, Garfield Memorial Fund, Abbott Laboratories, Amarin Pharma, Inc., Bayer, Cordio Medical, Edwards Lifesciences LLC, Esperion Therapeutics, Inc., Merck, and Novartis. Dr. Steinman has received royalties from UptoDate and honoraria from the American Geriatrics Society.

Source: Journal of the American Geriatrics Society

DOI: 10.1111/jgs.19224

Authors: Parag Goyal, Samprit Banerjee, Michael A. Steinman, Andrew P. Ambrosy

Institutions: Weill Cornell Medicine, University of California, San Francisco, San Francisco VA Health Care System, Kaiser Permanente San Francisco Medical Center, Kaiser Permanente Northern California

Language: English

Topic: Statistical Methods in Clinical Trials

Subfield: Statistics and Probability

Field: Mathematics

Domain: Physical Sciences

SDG: Good health and well-being

Open Access status: green

Funders: American Heart Association, National Institutes of Health, National Institute on Aging, National Heart, Lung, and Blood Institute